Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial

被引:0
作者
Yan Li
Yafei Fu
Kai Wang
Zhiming Liu
Xiaoqing Shi
Mingwei Zhao
机构
[1] Peking University People’s Hospital,Department of Ophthalmology
[2] Peking University People’s Hospital,Eye Diseases and Optometry Medical Research Institute
[3] Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases,College of Optometry
[4] Peking University Health Science Center,undefined
来源
Trials | / 21卷
关键词
Myopia; Progression; Prospective; Multicenter; Trial; Myopic defocus; Spectacle lens;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 148 条
[1]  
Holden BA(2016)Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050 Ophthalmology 123 1036-1042
[2]  
Fricke TR(2019)IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies Invest Ophthalmol Vis Sci. 60 M20-M30
[3]  
Wilson DA(2019)Myopia - a 21st century public health issue Invest Ophthalmol Vis Sci. 60 Mi-Mii
[4]  
Jong M(2018)The epidemics of myopia: aetiology and prevention Prog Retin Eye Res. 62 134-149
[5]  
Naidoo KS(2019)Myopic maculopathy: current status and proposal for a new classification and grading system (ATN) Prog Retin Eye Res. 69 80-115
[6]  
Sankaridurg P(2019)IMI - myopia control reports overview and introduction Invest Ophthalmol Vis Sci 60 M1-19
[7]  
Wong TY(2019)IMI - clinical management guidelines report Invest Ophthalmol Vis Sci. 60 M184-M203
[8]  
Naduvilath TJ(2019)IMI - Interventions Myopia Institute: interventions for controlling myopia onset and progression report Invest Ophthalmol Vis Sci. 60 M106-M131
[9]  
Resnikoff S(2004)Homeostasis of eye growth and the question of myopia Neuron 43 447-468
[10]  
Flitcroft DI(2019)Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial British Journal of Ophthalmology 104 363-368